Pharm 2 lectures: cancer bio & cancer chemo Flashcards

1
Q

What is anchorage dependence for proliferation?

A

Cells depend on their integrins (transmemb prots) interacting with ECM to proliferate
-Cancer cells dont follow this!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 6 “hallmarks of cancer” according to the Weinberg model of tumor progression?

A
#1 Self sufficiency in growth signals: oncogenes
#2 Sensitivity to negative signals: TSGs
#3 Evasion of apoptosis 
#4 Acquisition of limitless proliferative capacity 
#5 Sustained angiogenesis
#6 Tissue invasion and metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hallmark #1 self sufficiency in growth signals: oncogenes

A

deletion or point mutation in protooncogene (GFs, Rs, signaling enzs, TFs) coding seq can cause hyperactive protein to be made, amplification can cause prot to be overproduced, and chrom translocation near DNA regulatory seq can cause normal protein to be overproduced or fusion protein to be produced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RAS

A

point mutatiosn in ras can make it const active, causing cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hallmark #2 Insensitivity to negative signals (TSGs)

A

TSGs inhibit cell growth, but if inactivated (via pt mutation, deletion in chrom, methylation at promotor, LOH, and transcr/posttranscr regulation), will end up allowing cells to prolif (brake pedals, causes apoptosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MDM2 significance w. p53 phosphorylation

A

When MDM2 phosphorylates p53 at a SPECIFIC SITE, it becomes tagged for proteasome degradation and expr is decr, causing decr apop, causing tumor growth.
(So INCREASED MDM2 activity phos/decr p53, causing cancer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2 examples of TSGs

A

p53, Rb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Therapies targeting CDKs/cyclins?

A

Want to INACTIVATE cyclins/CDKs with INHIBITORS, so they don’t phosphorylate Rb. Rb stays bound to E2F, thus it continues to do what in normally does (Rb continues to prevent transcr of E2F since it’s bound)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Overall, how do CDK inhibitors work on Rb?

A

CDK inhibitors inhibit CDKs/cyclins from phosphorylating Rb, preventing it from being unbound to E2F, keeping it bound, and thus preventing an increase in proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the 2 ways to init apoptosis?

Tx via caspase?

A

Extrinsic path where env signals/cytokines bind to death receptors, activating caspases causing cell death, and
Intrinsic path where there’s intracell oxidative stress that acitvates mito, acitv caspases, causing cell death
-Increase caspase activity to incr apop! (esp casp 8&9)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do cancers have limitless prolif capacity (role of telomeres?)

A

Cancers prevent their telomeres from shortening w/ replications (eg inactivating p53 or Rb extends lifespan, mutations can activate telomerase and keep telomeres there)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Order of cell cycle phases

A

G0, can then go into G1 with growth signal

G1 (commits), S, G2, M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the checkpoints at each phase of cell cycle (3)

A

G1: dna dmg repaired
G2: checks that all chrom are repl, check for dna dmg
M: check that all chrom attached to spindle correctly at meta plate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which CDKs are targets for drugs? (CDKs are prots that regulate cell cycle at each step, want to inhib to prevent cycle progression)

A

CDK4&6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do telomerase inhibs work

A

TERG gene encodes telomerase RT, increasing telomerase expr, which keeps telomeres in cells, causing cancer (by decr apop)
-More telomerase activity means more aggro tumor!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 3 examples of pro-angiogenic factors

A

VEGF, FGF1, FGF2 (activated in tumors and signal cell endoth bv cell prolif)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Steps of angiogenesis

A

Signaling molecs (angiogen factors) bind to endoth cell and pericyte receptors, endoth grows, endoth degrades BM, invade ECM and forms tubes, pericytes/mesenchyme cells secrete Ang-1, binds to Tie-2 on endoth cells inducing vessel stabilization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Tx involving angiogenesis

A
  • Suppress angiogenesis via antibodies which can bind/suppress VEGF
  • TKIs can also inhib angio
  • Akt/MTOR inhibs block signaling after VEGF binds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

CSC Tx

A

Cancer Stem Cells can cause tumor relapse, want to target/destroy these

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Reviewing 6 Hallmarks of cancer and examples

A
1: activate H-ras oncogene
2 lose Rb suppressor
3 produce IGF survival factors
4 turn on telomerase (keeps chrom integrity and inhib apop)
5 Produce VEGF inducer
6 inactivate E-cadherin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What do alkylating agents do

A

alkylate dna at n7 of guanine to prevent S phase replication (from mispairing/strand breakage)

22
Q

3 examples of alkylating agents

Toxicity?

A

cyclophosphamide
nitrogen mustard
platinum coordination complexes
Toxicity: bone marrow with platelet and wbc deficiency

23
Q

Cyclophosphamide? sxe?

A

alkylating agent that crosslinks dna

sxe: acrolein causes hemorrhagic cysts

24
Q

platinum coordination complexes? sxe?

A

cisplatin forms dna crosslinks

sxe: NEPHROTOXIC, emesis etc (platinum excreted from kidneys)

25
Q

CHEMOTHERAPY DRUG TYPES

A
alkylating agents
anti-metabolites
plant alkaloids
antibiotics
anthrycylines, topo inhibs, natural prods, vinca alkaloids, taxanes, plat analogs
26
Q

3 types of anti-metabolites

A

anti folate (analogs)
anti purines
anti pyrimidines

27
Q

Anti folates and examples (5-FU)

A

folic acid analogs

  • Methotrexacte is a DHF analog, inhibits DHFR and suppresses folate synth
  • 5-FU inhibits thy synthase and terminates dna synth (can also block RNA synth)
28
Q

Sxe of anti-metabolites

A
  • Tumor lysis syndrome: inflamm cells come to tumor death area (cytokine storm)
  • palmar plantar dysesthesia (hand foot syndrome), stevens-johnson syndrome (skin rxn), epidermal necroylysis
  • literally any system
29
Q

What is leukovorin rescue for

A

if getting methotrexate toxicity, leukovorin used to counteract DHFR inhib, to protect bone marrow -increases efficacy of 5FU
-but cancers can still develop resistance to this!

30
Q

antipyrimidine examples

and SxE? (cytarabine)

A

De-oxy-cytidine analogs (differ in 2’ position) conv to triphosphate forms
-cytarabine: inhib DNA poly, inc into dna strand, causes mutation so induces tumor cell differentiation (less stem cell like/less aggro), SxE is bone marrow suppr

31
Q

Taxanes and sxe

A

plant alk, inhibits microtubules to prevent mitosis (spindle poison) “-taxel”
Sxe:
-pacli: decr WBCs. platelets, PNS
-doce: bone marrow supp, neurotoxic, fluid retention

32
Q

Vinca alkaloids and sxe

A

bind to tubulin and depolymerize, metaphasic arrest

-vineblastine (sxe BONE MARROW SUPPR, alopecia nausea), vincristine (muscle weakness, PERIPH NEURITIS)

33
Q

Topoisomerase inhibs

A

Topo I makes single strand breaks, II makes double

  • Camptothecins (mess up topo I) such as topotecan (causes wbc/platelet decr), and irinotecan (prodrug, met, sxe is DIARRHEA and myelotoxicity), “tecans”
  • ANTHRACYCLINES (mess up topo II), “rubicins” generate ROS which leads to sxe (cardiac toxicity, lipid perox dmg to mito memb)
34
Q

Antibiotic example

A

Bleomycin: creates ROS by forming dna complex with iron and breaks strand (sxe PULM FIBROSIS)

35
Q

Review: what are the m phase specific antimicrotubule agents?

A

taxanes, vinca alkaloids

36
Q

What are the topo II inhibitors

A

anthracyclines

Topo I is Camptothecins like irinotecan

37
Q

what are the S phase specific drugs

A

folate/purine/pyrimidine analogs

38
Q

adv/disadv of neoadjuvant chemo

A

primary given before surgery

adv: treats metasteses early
disadv: relies on clinical staging, could overtreat

39
Q

adv/disadv of adjuvant chemo

A

used after surgery to prevent regrowth, prevents micrometases

adv: relies on if patients actually needs it, watchful waiting
disadv: pt compliance

40
Q

Combo therapy adv

A
  • combo therapy decr sxe by decr conc
  • could by synergistic,
  • cross resistance difficult for cancer
41
Q

Toxicity vs resistance

A

Want higher level of drug so resistance doesnt happen but at level that is tolerated by pt

42
Q

Resistance methods

A
  • Epithelial-mesenchymal transition: differentiated tumors can change epith cells to mesenchyme from inflam and become more res
  • altered drug targets, dec activation/incr inact
  • host dep mechs (drug barriers etc)
43
Q

which compound is the most emetic

A

cisplatin!

44
Q

Adrimycin toxicity

A

cardiotoxic!

45
Q

Cyclophosphamide tox

A

Hemorrhagic cystitis

46
Q

bleomycin tox

A

pulm tox

47
Q

Vincas tox

A

neuropathy, constipation

48
Q

Taxanes tox

A

neuropathy

49
Q

anthracyclines tox

A

(daunorubicin)

cardiac toxicity

50
Q

alkylating agents tox

A

secondary leukemias

51
Q

Tamoxifen Toxicity

A

uterine cancer, thrombosis